Since other kinases, such as ERK and AKT, can regulate the activation of DRP1 in lung adenocarcinoma cell lines, the GTPase activity of DRP1 can thus be maintained even though CDK2 is depleted. The gene discussed is DNM1L; the disease is lung adenocarcinoma.